CYTK
CYTOKINETICS INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 5 ▲ Cytokinetics announced positive topline results from the ACACIA-HCM…
- Jun 30 ▲ 4 funds open new positions (13F)
- Jul 21 to Jul 30 ▼ 3 days of insider sells: $2.0M by 3 insiders, avg $80.28
- Aug 10 ▼ 1 insider sell $575.7K at $76.76
- Aug 18 ▼ 1 insider sell $265.4K at $75.82
- Aug 31 to Sep 28 ▼ 8 days of insider sells: $10.1M by 5 insiders, avg $69.71
- Sep 29 ▲ Gilbert Cisneros bought $1,001 - $15,000, last disclosed Oct 13
- Oct 6 to Oct 12 ▼ 2 days of insider sells: $686.4K by 2 insiders, avg $62.40
- Oct 16 William Blair initiates
- Oct 20 ▼ 1 insider sell $224.0K at $64.01
- Nov 2 to Nov 9 ▼ 3 days of insider sells: $965.0K by 3 insiders, avg $60.31
- Nov 9 FDA: Cytokinetics Announces Additional Data Related to Aficamte…
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders sold $14.8M.
- InstitutionsBULLISH
Q2 2026: 60 added (4 new), 20 trimmed or exited. Largest new: Holocene Advisors $97.5M, Hood River Capital Management $40.0M.
- AnalystsBULLISH
25 of 28 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest −3.8% to 17.93M shares. 14.2 days to cover, ≈12.9% of shares.
- TrendDOWNTREND
17% below its 50-day average. New closing low $53.17 on Nov 16.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | TRIM | $428.7M |
| Avoro Capital Advisors LLC | ADD | $425.9M |
| BANK OF AMERICA CORP /DE/ | ADD | $394.9M |
| Polar Capital Holdings Plc | ADD | $192.0M |
| Capital Research Global Investors | DOUBLED | $143.7M |
| JPMORGAN CHASE & CO | ADD | $139.2M |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | ADD | $136.6M |
| Point72 Asset Management, L.P. | DOUBLED | $135.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
28 analystsPrice is below the lowest target. Median implies +101%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | Citigroup MAINTAIN | Buy |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Oct 19, 2026 | HC Wainwright & Co. REITERATE | Buy |
| Oct 16, 2026 | William Blair INITIATE | Outperform |
| Oct 8, 2026 | RBC Capital MAINTAIN | Outperform |
| Aug 31, 2026 | HC Wainwright & Co. REITERATE | Buy |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
PARSHALL B LYNNE Director Nov 9, 2026 | SELL | $132.4K |
PARSHALL B LYNNE Director Nov 9, 2026 | SELL | $141.2K |
Malik Fady Ibraham EVP Research & Development Nov 3, 2026 | EXERCISE | $27.3K |
Malik Fady Ibraham EVP Research & Development Nov 3, 2026 | SELL | $220.3K |
Blum Robert I President & CEO Nov 2, 2026 | SELL | $471.1K |
Blum Robert I President & CEO Nov 2, 2026 | EXERCISE | $79.5K |
Malik Fady Ibraham EVP Research & Development Oct 20, 2026 | EXERCISE | $27.3K |
Malik Fady Ibraham EVP Research & Development Oct 20, 2026 | SELL | $224.0K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$1.28 | -$1.55–-$0.73 | +3.9% | $75.3M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
37 filings · 9 press releases · 2 bullish · 6 bearish · 3 mixed · 26 neutral- NEUTRAL SC 13G/ANov 16, 2026
Wellington Management Group LLP filed an amended Schedule 13G disclosing a 7.7% passive stake in Cytokinetics as of September 30, 2026, up from a prior filing. The increase is routine for a passive asset manager and does not signal activist intent.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL CLUSTERNov 12, 2026
Three Cytokinetics insiders, including the CEO and EVP of R&D, sold a total of $824K in…
All sales were pre-planned under 10b5-1 plans, so the cluster does not signal a change in insider sentiment. Monitor the upcoming supplemental NDA filing for aficamten and any subsequent insider…
- NEUTRAL SC 13GNov 10, 2026
State Street Corp disclosed a 5.1% passive stake in Cytokinetics via Schedule 13G, holding…
State Street's new 5.1% passive stake adds to institutional ownership concentration alongside Fidelity and Vanguard. Monitor future 13G amendments for position changes and any potential conversion…
- NEUTRAL 144Nov 9, 2026
Director B. Lynne Parshall filed a Form 144 notice of intent to sell 5,000 shares of Cytokinetics…
The sale is small relative to market cap and conducted under a pre-arranged 10b5-1 plan, reducing the likelihood of opportunistic insider selling. Monitor the company's upcoming earnings and any…
All CYTK filing & press-release reports (46)
- SC 13G/A reportNov 16, 2026
- CLUSTER reportNov 12, 2026
- SC 13G reportNov 10, 2026
- 144 reportNov 9, 2026
- INST-CLUSTER reportNov 9, 2026
- PRESS-RELEASE reportNov 9, 2026
- 8-K reportNov 4, 2026
- PRESS-RELEASE reportNov 4, 2026
- CLUSTER reportNov 3, 2026
- PRESS-RELEASE reportNov 2, 2026
- PRESS-RELEASE reportOct 21, 2026
- CLUSTER reportSep 28, 2026
- CLUSTER reportSep 22, 2026
- CLUSTER reportSep 15, 2026
- CLUSTER reportSep 11, 2026
- CLUSTER reportSep 8, 2026
- CLUSTER reportSep 1, 2026
- CLUSTER reportAug 31, 2026
- PRESS-RELEASE reportAug 29, 2026
- 8-K reportAug 28, 2026
- CLUSTER reportJul 30, 2026
- CLUSTER reportJul 27, 2026
- PRESS-RELEASE reportJul 23, 2026
- CLUSTER reportJul 14, 2026
- CLUSTER reportJul 7, 2026
- CLUSTER reportJul 2, 2026
- CLUSTER reportJun 29, 2026
- CLUSTER reportJun 15, 2026
- CLUSTER reportJun 1, 2026
- CLUSTER reportMay 20, 2026
- PRESS-RELEASE reportMay 11, 2026
- PRESS-RELEASE reportMay 8, 2026
- PRESS-RELEASE reportMay 6, 2026
- 424B5 reportMay 5, 2026
- CLUSTER reportMay 5, 2026
- CLUSTER reportMay 5, 2026
- 8-K reportMay 5, 2026
- PRESS-RELEASE reportMay 5, 2026
- PRESS-RELEASE reportMay 4, 2026
- PRESS-RELEASE reportApr 28, 2026
- PRESS-RELEASE reportApr 21, 2026
- CLUSTER reportApr 15, 2026
- CLUSTER reportMar 31, 2026
- 144 reportApr 7, 2026
- CLUSTER reportMar 31, 2026
- 8-K reportFeb 24, 2026